2018 Spring MCELLBI 88 001 LEC 001

2018 Spring

MCELLBI 88 001 - LEC 001

Immunotherapy of Cancer: Success and Failures

Nilabh Shastri

Jan 16, 2018 - May 04, 2018
Mo
02:00 pm - 02:59 pm
Class #:32863
Units: 2

Offered through Molecular and Cell Biology

Current Enrollment

Total Open Seats: 0
Enrolled:
Waitlisted:
Capacity:
Waitlist Max:
No Reserved Seats

Hours & Workload

1 hours of instructor presentation of course materials per week, 4 hours of outside work hours per week, and 1 hours of instructional experiences requiring special laboratory equipment and facilities per week.

Other classes by Nilabh Shastri

Course Catalog Description

We will work with a variety of datasets that describe a molecular view of cells and how they divide. We will learn about the processes that cause cells to become specialized (differentiate) and to give rise to cancer (transform). We will analyze data on genetic mutations in cancer that distinguish tumor cells from normal cells. We will learn how mutations are detected by the immune system and the basis of cancer immunotherapy. Finally we will analyze data on clinical trials of cancer immunotherapy to define the correlates of success in curing the disease. The students are expected to gain an understanding of data that reveals the basics of cell physiology and cancer, how immunotherapies of cancer work and their current limitations.

Rules & Requirements

Repeat Rules

Course is not repeatable for credit.

Reserved Seats

Current Enrollment

No Reserved Seats

Textbooks & Materials

Textbook information is not available for Spring 2018.

Associated Sections